Adjustable intraocular implant

US10195079B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10195079-B2
Application numberUS-201615157240-A
CountryUS
Kind codeB2
Filing dateMay 17, 2016
Priority dateFeb 19, 2013
Publication dateFeb 5, 2019
Grant dateFeb 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.

First claim

Opening claim text (preview).

What is claimed is: 1. A shunt for draining fluid from an anterior chamber of an eye, the shunt comprising: a main section having an inlet, an outlet, and a wall defining a lumen with a first cross-sectional area and being configured to direct the fluid from the anterior chamber through the inlet toward the outlet such that, when positioned in the eye, fluid is released through the outlet at a location having lower pressure than the anterior chamber; a first detachable flow restriction section, positioned at the outlet, in fluid communication with the main section, the first detachable flow restriction section having a second cross-sectional area that is less that the first cross-sectional area; a second, permanent, detachable flow restriction section, positioned at the inlet, in fluid communication with the main section, the second detachable flow restriction section having a third cross-sectional area that is less that the first cross-sectional area, the second detachable flow restriction section being severable to adjust a flow of fluid through the shunt; and a pharmaceutical or biological agent deliverable to the eye. 2. The shunt of claim 1 , wherein the main section is formed from a separate material from the first and second detachable flow restriction sections. 3. The shunt of claim 1 , wherein the first detachable flow restriction section is dissolvable. 4. The shunt of claim 1 , wherein the first detachable flow restriction section comprises first and second portions that are concentrically layered within the lumen. 5. The shunt of claim 1 , wherein the first detachable flow restriction section comprises first and second portions, the first portion having a first dissolution rate, and the second portion having a second dissolution rate different from the first dissolution rate. 6. The shunt of claim 1 , wherein the first or second detachable flow restriction section comprises the pharmaceutical or biological agent. 7. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a coating on an exterior surface of the main section. 8. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a coating on an interior surface of the main section. 9. The shunt of claim 1 , wherein a portion of the shunt is impregnated with the pharmaceutical or biological agent. 10. The shunt of claim 1 , wherein the pharmaceutical or biological agent comprises a time-release pharmaceutical or biological agent. 11. The shunt of claim 1 , wherein the second, permanent, detachable flow restriction section comprises a cross-linked gelatin. 12. The shunt of claim 11 , wherein the second, permanent, detachable flow restriction section comprises a cross-linked gelatin subjected to a crosslinker.

Assignees

Inventors

Classifications

  • Materials for coatings · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

  • Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002) · CPC title

  • Eyes · CPC title

  • Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10195079B2 cover?
Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be p…
Who is the assignee on this patent?
Aquesys Inc
What technology area does this patent fall under?
Primary CPC classification A61F9/00781. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).